(Medical Xpress)—A cellular pathway interaction known as TWEAK-Fn14, often associated with repair of acute injuries, also is a viable target for drug therapy that could prevent the spread of cancer, especially brain cancer, ...
Nov 8, 2013
0
0
A Phase I/II, multi-center trial designed to test the safety and preliminary efficacy of a first in class cancer treatment opened worldwide today at the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, ...
Aug 29, 2012
0
0
A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard ...
Jan 22, 2013
0
0
Though survival rates for children diagnosed with cancer are improving, not all children respond to current medical treatments. Cancers in children, adolescents and young adults can be resistant to medical treatments or recur ...
Oct 5, 2021
0
7
Researchers at the Translational Genomics Research Institute (TGen) have developed a method of isolating biospecimens that could lead to a less costly, less invasive and more accurate way of diagnosing chronic kidney disease, ...
Jul 11, 2012
0
0
For decades, ultrasound has been used to image organs such as the heart and kidneys, check blood flow, monitor the development of fetuses, reduce pain and even break up kidney stones.
Mar 19, 2018
0
3
In a scientific first, the fusion of two genes, ALK and EML4, has been identified as the genetic driver in an aggressive type of thyroid cancer, according to a study by the Translational Genomics Research Institute (TGen).
Mar 19, 2014
0
0
A groundbreaking study of nearly 2,300 extremely obese diabetes patients, led by the Translational Genomics Research Institute (TGen), has identified genes associated with unhealthy liver function.
Oct 1, 2013
0
0
Since mid-January, the Translational Genomics Research Institute (TGen) has joined the world-wide effort to test for the SARS-CoV-2 virus causing the COVID-19 disease. Acting as Genomic First Responders, TGen, an affiliate ...
Mar 31, 2020
0
1
Genomic sequencing has revealed therapeutic drug targets for difficult-to-treat, metastatic triple-negative breast cancer (TNBC), according to an unprecedented study by the Translational Genomic Research Institute (TGen) ...
Dec 6, 2012
0
0
